dc.contributor | Departament de Salut |
dc.date.accessioned | 2018-10-29T13:37:10Z |
dc.date.available | 2018-10-29T13:37:10Z |
dc.date.issued | 2017-11-17 |
dc.identifier.citation | Teduglutida per al tractament de la síndrome de l'intestí curt. Barcelona: Servei Català de la Salut; 2017. |
dc.identifier.uri | https://hdl.handle.net/11351/3637 |
dc.description | Teduglutida; Short bowel syndrome; Treatment |
dc.description.abstract | Short Intestinal Syndrome (SIC) is a complex minority condition caused by the functional or anatomical loss of large intestinal segments that seriously compromise the absorption capacity. The most common aetiology in adults are surgical resections, either for mesenteric ischaemia, traumatism, radiation enteritis, Crohn's disease or bowel obstruction. In children, the main causes of SIC are congenital and perinatal diseases such as necrotizing enterocolitis, defects in the abdominal wall and Hirschsprung disease, among others |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.relation.ispartof | Programa d'harmonització farmacoteràpeutica, Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Intestins - Obstruccions |
dc.subject | Intestins - Malalties - Tractament |
dc.subject | Medicaments - Assaigs clínics |
dc.subject.mesh | Short Bowel Syndrome |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Drug Evaluation |
dc.title | Teduglutida per al tractament de la síndrome de l'intestí curt |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | síndrome del intestino corto |
dc.subject.decs | /tratamiento farmacológico |
dc.subject.decs | evaluación de medicamentos |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |